Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$41.57 USD
-0.88 (-2.07%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $41.61 +0.04 (0.10%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 28% (71 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.57 | 1.42 | 9.99 |
Current Quarter Estimate | 0.78 | 1.25 | 61.00 |
Year Ago Quarter Estimate | 0.65 | -4.28 | 54.84 |
Next Quarter Estimate | 0.98 | 1.37 | 63.00 |
Next Year Estimate | 4.45 | 7.08 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 14.46 | 12.50 | 15.67 |
Next Year | 17.11 | 15.30 | 11.34 |
Last 5 Years | 55.00 | 0.10 | 8.10 |
Next 5 Years | 15.80 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 11.18 | 1.64 |
Price/Book (MRQ) | 3.02 | 1.48 |
Price/Cash Flow (MRFY) | 9.52 | 11.05 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 22.88% | NA |
Return on Equity (TTM) | 29.17% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.